[go: up one dir, main page]

DE60333903D1 - Antimikrobielle therapeutische zusammensetzungen und ihre verwendung - Google Patents

Antimikrobielle therapeutische zusammensetzungen und ihre verwendung

Info

Publication number
DE60333903D1
DE60333903D1 DE60333903T DE60333903T DE60333903D1 DE 60333903 D1 DE60333903 D1 DE 60333903D1 DE 60333903 T DE60333903 T DE 60333903T DE 60333903 T DE60333903 T DE 60333903T DE 60333903 D1 DE60333903 D1 DE 60333903D1
Authority
DE
Germany
Prior art keywords
infections
intended
therapeutic compositions
antimicrobial
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60333903T
Other languages
English (en)
Inventor
Dusan Dr Ninkov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60333903D1 publication Critical patent/DE60333903D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60333903T 2002-02-20 2003-02-18 Antimikrobielle therapeutische zusammensetzungen und ihre verwendung Expired - Lifetime DE60333903D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35906902P 2002-02-20 2002-02-20
PCT/US2003/004910 WO2003069993A1 (en) 2002-02-20 2003-02-18 Antimicrobial therapeutic compositions and methods of use

Publications (1)

Publication Number Publication Date
DE60333903D1 true DE60333903D1 (de) 2010-10-07

Family

ID=27757769

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60333903T Expired - Lifetime DE60333903D1 (de) 2002-02-20 2003-02-18 Antimikrobielle therapeutische zusammensetzungen und ihre verwendung

Country Status (7)

Country Link
US (1) US6921539B2 (de)
EP (1) EP1482791B1 (de)
AT (1) ATE478684T1 (de)
AU (1) AU2003211149A1 (de)
DE (1) DE60333903D1 (de)
ES (1) ES2351116T3 (de)
WO (1) WO2003069993A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7214392B2 (en) * 2003-02-25 2007-05-08 Bio-Botanica, Inc. Process and composition for inhibiting growth of microorganisms
US7622269B2 (en) 2004-03-19 2009-11-24 Tyratech, Inc. Methods of screening tyramine- and octopamine-expressing cells for compounds and compositions having potential insect control activity
US7541155B2 (en) 2003-04-24 2009-06-02 Tyratech, Inc. Methods of screening compositions for potential insect control activity
PL1711058T3 (pl) 2004-01-23 2022-02-07 Eden Research Plc Sposoby zabijania nicieni obejmujące aplikację składnika terpenowego
PT2338332E (pt) * 2004-05-20 2014-05-15 Eden Research Plc Partícula oca de glucano ou partícula de parede celular que encapsula um componente de terpeno
WO2006120495A1 (fr) * 2005-05-13 2006-11-16 Advanced Scientific Developements Composition pharmaceutique comprenant un antiviral, an antitumoral ou un antiparasitaire, et un actif choisi parmi le carveol, le thymol, l’eugenol, le borneol et le carvacrol
WO2007063267A1 (en) 2005-11-30 2007-06-07 Eden Research Plc Terpene-containing compositions and methods of making and using them
KR101478012B1 (ko) 2005-11-30 2015-01-02 에덴 리서치 피엘씨 티몰, 유게놀, 게라니올, 시트랄, 및 ｌ―카르본에서 선택된 테르펜 또는 테르펜 혼합물을 포함하는 조성물 및 방법
US20070167408A1 (en) * 2005-12-19 2007-07-19 Zentaris Gmbh Novel alkyl phospholipid derivatives with reduced cytotoxicity and uses thereof
US8753676B2 (en) 2006-02-15 2014-06-17 Botanocap Ltd. Applications of microencapsulated essential oils
US20080032021A1 (en) * 2006-05-19 2008-02-07 Faltys Gary L Feed supplements for ruminants including essential oil compounds and organic acids
WO2008003007A2 (en) 2006-06-27 2008-01-03 Tyratech, Inc. Compositions and methods for treating parasitic infections
US8685471B2 (en) * 2006-07-17 2014-04-01 Tyratech, Inc. Compositions and methods for controlling insects
WO2008124836A2 (en) * 2007-04-10 2008-10-16 Uwm Research Foundation, Inc. Methods of reducing virulence in bacteria
GB2450082B (en) 2007-06-11 2011-07-06 Omex Internat Nematode control agent
WO2009111685A1 (en) 2008-03-06 2009-09-11 Sensient Flavors Llc Herbal extracts and flavor systems for oral products and methods of making the same
US9968564B2 (en) 2009-06-05 2018-05-15 Intercontinental Great Brands Llc Delivery of functional compounds
US20100310726A1 (en) 2009-06-05 2010-12-09 Kraft Foods Global Brands Llc Novel Preparation of an Enteric Release System
US20100307542A1 (en) * 2009-06-05 2010-12-09 Kraft Foods Global Brands Llc Method of Reducing Surface Oil on Encapsulated Material
US8859003B2 (en) * 2009-06-05 2014-10-14 Intercontinental Great Brands Llc Preparation of an enteric release system
CN102883602B (zh) 2010-02-16 2017-07-18 Uwm研究基金会有限公司 降低细菌的毒力的方法
US8597695B1 (en) * 2010-11-13 2013-12-03 Sirbal Ltd. Herbal combinations for treatment of a skin condition
WO2012076717A1 (en) * 2010-12-09 2012-06-14 Societe De Developpement Scientifique - Sds Pharmaceutical composition comprising trans-cinnamaldehyde and its use in the treatment of infections
WO2012088279A1 (en) * 2010-12-23 2012-06-28 Pirzada Syed Zebe Blue curls "pirzada" and related compositions and methods
GB201220940D0 (en) 2012-11-21 2013-01-02 Eden Research Plc Method P
US8859005B2 (en) 2012-12-03 2014-10-14 Intercontinental Great Brands Llc Enteric delivery of functional ingredients suitable for hot comestible applications
CN103053529B (zh) * 2012-12-29 2014-12-31 广东中迅农科股份有限公司 香芹酚和氟啶胺的农药组合物
US20140336271A1 (en) * 2013-05-07 2014-11-13 Kemin Industries, Inc. Antimicrobial Compositions Containing Carvacrol and Thymol
EP3991725B1 (de) 2020-11-02 2026-01-28 Dusan Ninkov Neues enteroantiseptikum zur behandlung gastrointestinaler infektionen bei menschen
ES3035955T3 (en) * 2020-12-17 2025-09-11 Conick Biotech Llc Inhaled liquid for the treatment of respiratory infections in humans caused by pathogens resistant to antibiotics
RS67106B1 (sr) * 2021-04-01 2025-09-30 Tesla Bioscience Ad Banja Luka Jedinjenje za lečenje bakterijskih infekcija različite etiologije kod ljudi
CN113956369B (zh) * 2021-10-21 2022-09-27 河南省医药科学研究院 一种三花莸多糖的制备方法及其应用
US20240374736A1 (en) * 2023-05-12 2024-11-14 Dusan Ninkov Inhaled liquid for the treatment of respiratory infections in humans caused by pathogens resistant to antibiotics

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2603583A (en) * 1949-03-04 1952-07-15 Welch Henry Pectin penicillin preparation
US2792329A (en) * 1950-04-13 1957-05-14 Glaxo Lab Ltd Aluminum stearate gelled mineral oil containing procaine penicillin with or without streptomycin or dihydrostreptomycin
US4034099A (en) * 1974-03-29 1977-07-05 The Upjohn Company Compositions and method for treating mastitis in milk animals
DK0904780T3 (da) * 1997-09-30 2004-02-23 D & W Trading B V Anvendelse af farmaceutiske præparater omfattende thymol og/eller carvacrol mod histomoniasis
US6299902B1 (en) 1999-05-19 2001-10-09 The University Of Georgia Research Foundation, Inc. Enhanced transdermal anesthesia of local anesthetic agents
US6509492B1 (en) * 2001-08-31 2003-01-21 First Horizon Pharmaceutical Corporation Tannate compositions and methods of treatment

Also Published As

Publication number Publication date
EP1482791B1 (de) 2010-08-25
ES2351116T3 (es) 2011-01-31
AU2003211149A1 (en) 2003-09-09
WO2003069993A1 (en) 2003-08-28
EP1482791A4 (de) 2007-04-04
ATE478684T1 (de) 2010-09-15
US6921539B2 (en) 2005-07-26
EP1482791A1 (de) 2004-12-08
US20030176364A1 (en) 2003-09-18

Similar Documents

Publication Publication Date Title
DE60333903D1 (de) Antimikrobielle therapeutische zusammensetzungen und ihre verwendung
EA200600689A1 (ru) Замещённые бензазолы и их применение в качестве ингибиторов raf киназы
ATE435015T1 (de) Substituierte benzazole und ihre verwendung als raf-kinase-hemmer
EA200401284A1 (ru) Замещённые бензазолы и их применение в качестве ингибиторов киназы raf
CO5700767A2 (es) Procedimiento de tratamiento de rechazo de transplantes
CR9929A (es) Nuevos compuestos
EA200601776A1 (ru) Метадоновые композиции местного действия и способы их применения
ECSP109953A (es) Derivados de piridazinona
ECSP077401A (es) Medicamentos que contienen compuestos de carbonilo y su uso
EA200800006A1 (ru) Триазолопиридины в качестве ингибиторов 11-бета-гидроксистероиддегидрогеназы типа i
NI200800060A (es) Bencimidazoles sustituidos como inhibidores de cinasa.
SV2008002958A (es) Uso de derivados de sulfamida heterociclo benzo-fusionado para el tratamiento del trastorno bipolar y mania referencia cruzada ref. prd2592sv
SG160436A1 (en) Polymer interlayers comprising skin layers
DE60329098D1 (de) Verwendung von mastix und dessen ätherischen ölen zur verhinderung oder bekämpfung von mikrobieller infektionen
MXPA06012961A (es) Ficotoxinas y usos de las mismas.
BR0100233B1 (pt) aditivo para aperfeiçoar as propriedades de fluxo frio de destilados intermediários, óleos combustìveis e uso de tal aditivo.
DE602004010915D1 (de) Verwendung eines antimykotischen echinocandin-mittels in kombination mit einem antibakteriellen glycopeptid-mittel
ATE549024T1 (de) Chinazolin-kaliumkanalhemmer
BRPI0513944A (pt) forma substancialmente pura de um composto de quinazolina, uso de um composto de quinazolina e composição
MA31630B1 (fr) Dérivés de 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamides et de 2,3,4,5-tetrahydropyrrolo[1,2-a][1,4]-diazépine-7-carboxamides, leur préparation et leur application en thérapeutique
ECSP055823A (es) DERIVADOS DE [6,7-DIHIDRO-5H-IMIDAZO[1,2-a]IMIDAZOL-3-SULFONILAMINO]-PROPIONAMIDA
TW200700358A (en) Organic compounds
BRPI0410808A (pt) (1s,5s)-3- (5,6-dicloro-3-piridinil)-3,6-diazabiciclo[3.2.0]heptano como um agente analgésico eficaz
DE602005027728D1 (de) Benzodiazepin-Derivate als ROCK-Kinasen Hemmer
AR043327A1 (es) Uso de inhibidores de quinurenina 3- hidroxilasa para el tratamiento de la diabetes